Rush University Medical Center invites applications for The Robert E. and Emily H. King Endowed Professor of Cancer Research in the Department of Internal Medicine, Division of Hematology, Oncology and Cell Therapy. Rush is seeking a Physician Scientist focused on immunotherapy in the treatment of lymphoma and hematologic cancers. The successful candidate will have a demonstrated history of grant funding and an established reputation in the field. In addition, they are Board Certified/Board Eligible and incoming at the associate or professor level. The predominant criteria include: a major commitment to research and scholarly activity that advances the field of medicine, teaching, excellence in clinical care, and institutional service appropriate to the programmatic need the individual is expected to fulfill.
The vision for The Robert E. and Emily H. King Cancer Immunotherapy Research Program is to develop the next generation of cellular and immunologic treatments for hematologic malignancies, setting its sights initially on lymphoma, leukemia, and myeloma. The central component of the King Cancer Immunotherapy Research Program is the endowed professorship that will support cancer research at Rush in perpetuity. The endowment provides support for laboratory staff and equipment.
Interested candidates, please address your CV and cover letter to:
Timothy M. Kuzel, MD, FACP
The Samuel G. Taylor III, MD, Professor of Oncology
Chief, Division of Hematology, Oncology and Cell Therapy
Rush University Medical Center is an Equal Opportunity/Affirmative action Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, disability or Protected Veteran status.
job, healthcare, licensure, medical, clinical, wellness, career, employment, opening, staff, benefits, health care, clinic, Chicago
Rush University Medical Center is consistently ranked as one of the nation’s top hospitals by U.S. News & World Report. Rush is also ranked in seven of 16 categories in U.S. News & World Report’s 2018-2019 “America’s Best Hospitals” issue, and is one of the two top-ranked hospitals in Illinois overall.
Rush is united by diversity, inclusion and a commitment to health equity. Rush is also a perennial “Leader in LGBT Healthcare Equality.”
Quality of life
Chicago offers an excellent selection of homes in downtown, suburban and rural locations, as well as public and private schools and colleges. Local museums, entertainment, culture and the arts are world-class. Celebrated restaurants, craft breweries and local distilleries abound.
Research at Rush
Rush is currently involved in more than 1,600 research studies, many NIH-funded. Rush’s long tradition of discovery dates back to determining the causes of scarlet fever, heart attacks and sickle cell anemia. Today we’re also leaders in neurosciences, cancer, immunology, infection, regenerative medicine and more. Join us in spearheading life-changing research at the national level.